MAPK1 and chronic obstructive pulmonary disease: Research has proven that p38 inhibition can reduce the release of various proinflammatory cytokines, including TNF‐α and granulocyte-macrophage colony-stimulating factor (GM‐CSF), from COPD macrophages.